Johnson and Johnson, Risperdal producer hit with $8B decision
The offended party’s lawyers contended the antipsychotic sedate at the middle is connected to unusual development of female bosom tissue in young men. PHILADELPHIA — A Philadelphia jury on Tuesday granted $8 billion in correctional harms against Johnson and Johnson and one if its backups